From: Sirtuins in kidney diseases: potential mechanism and therapeutic targets
Classification | Name | Structure | Target | Cell | Disease | Effect | Pathway | References | |
---|---|---|---|---|---|---|---|---|---|
Natural sirtuin agonists | Resveratrol |
| Sirt1 | Podocyte | DKD | Mitochondrial oxidative stress | Sirt1/PGC-1α | [172] | |
Sirt1 | / | Cadmium-induced nephrotoxicity | Mitophagy | Sirt1/PINK1/Parkin | [173] | ||||
Curcumin |
| Sirt1 | RTECs | Aristolochic acid nephropathy | Oxidative stress | Sirt1/Nrf2/HO-1 | [174] | ||
Silybin |
| Sirt3 | RTECs | Cisplatin-induced AKI | Mitochondrial dysfunction, apoptosis | / | [175] | ||
Honokiol |
| Sirt3 | RTECs | Cisplatin-induced AKI | Mitochondrial fission | Sirt3/AMPK | [176] | ||
Quercetin |
| Sirt1 | RTECs | Senescence and renal fibrosis | Mitophagy | Sirt1/PINK1/Parkin | [41] | ||
Isoliquiritigenin |
| Sirt1 | NRK-52E cells | STZ-induced DKD | Inflammation, oxidative stress | Sirt1/MAPKs, Sirt1/Nrf2 | [177] | ||
Sirt1 | / | STZ-induced DKD | Inflammation | Sirt1/NF-κB; Sirt1/NLRP3 | [178] | ||||
Synthetic sirtuin agonists | SRT1720 |
| Sirt1 | Podocytes | DKD | Autophagy | Sirt1/NF-κB p65 | [133] | |
SRT3025 |
| Sirt1 | NRK-49F cells | Senescence and renal fibrosis | Fibrogenesis | Sirt1/TGF-β | [179] | ||
MDL-800 |
| Sirt6 | RTECs | UUO | Inflammation, Fibrosis | Sirt6/β-Catenin;TGF-β1/Smad | [155] | ||
SRT2183 |
| Sirt1 | Renal medullary interstitial cells | UUO | Oxidative stress, apoptosis, fibrosis | Sirt1/COX2 | [180] | ||
NAD+ promoter | NMN |
| Sirt1 | Podocytes | Focal glomerulosclerosis | Histone methylation | NMN/NAD | [181] | |
DKD | Histone methylation | Sirt1/Claudin-1 | [182] | ||||||
NR |
| Sirt3 | Podocytes | CKD | Mitochondrial Dysfunction, Oxidative stress | Sirt3/PGC-1α | [183] | ||
Sirtuins inhibitors | AGK2 |
| Sirt2 | RTECs | AKI | Apoptosis | Sirt2/FOXO3a | [81] | |
Sirt2 | NRK-49F cells | UUO | Fibrosis | Sirt2/EGFR/PDGFRβ | [82] |